Conclusions
In summary, the LOS of B. pertussis lacks the long-chain polysaccharide O antigen, and is resolved electrophoretically into two distinct bands designated LOS A and LOS B. Mice administered with anti-LOS A mAbs can be protected from fatal B. pertussis infection. These observations may indicate potential for oligosaccharides as a component of new acellular pertussis vaccines. Studies performed thus far also suggest that idiotypic profiles influence the protective value of antibodies and that several antibody-mediated effector functions may participate in the protection. Further research investigating the factors inducing protective immunity is needed for a better definition of new vaccine formulations.
Similar content being viewed by others
References
Ackers JP, Dolby JM (1972) The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection in mice. J Gen Microbiol 70:371
Amano KI, Fukushi K, Watanabe M (1990) Biochemical and immunological comparison of lipopolysaccharides from Bordetella species. J Gen Microbiol 136:481
Aprile MA, Wardlaw AC (1973) Immunochemical studies on the lipopolysaccharides of Bordetella pertussis. Can J Microbiol 19:231
Archambault D, Rondeau P, Martin D, Brodeur BR (1991) Characterization and comparative bactericidal activity of monoclonal antibodies to Bordetella pertussis lipo-oligosaccharide A. J Gen Microbiol 137:905
Arciniego JL, Hewlett EL, Johnson FD, Deforest A, Wassilak SGF, Onorato IM, Manclark CR, Burns DL (1991) Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis 163:135
Armstrong SK, Parker CD (1986) Surface proteins of Bordetella pertussis: comparison of virulent and avirulent strains and effects of phenotypic modulation. Infect Immun 54:308
Ashworth LAE, Fitzgeorge RB, Irons LI, Morgan CP, Robinson A (1982) Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels. J Hyg 88:475
Ashworth LAE, Robinson A, Irons LI, Morgan CP (1983) Antigens in whooping cough vaccine and antibody levels induced by vaccination of children. Lancet II:878
Ayme G, Caroff M, Chaby R, Haeffner-Cavaillon N, LeDur A, Moreau M, Muset M, Mynard MC, Roumiantzeff M, Schulz D, Szabo L (1980) Biological activities of fragments derived from Bordetella pertussis endotoxin: isolation of a nontoxic, Shwartzman-negative lipid A possessing high adjuvant properties. Infect Immun 27:739
Briles DE, Forman C, Hudak S, Claflin JL (1982) Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 156:1177
Brodeur BR, Hamel J, Martin D, Rondeau P (1991) Biological activity of a human monoclonal antibody to Bordetella pertussis lipooligosaccharide. Hum Antibod Hybridomas 2:194
Caroff M, Lebbar S, Szabo L (1987) Detection of 3-deoxy-2-octulosonic acid in thiobarbiturate negative endotoxins. Carbohydr Res 161:c4
Caroff M, Chaby R, Karibian D, Perry J, Deprun C, Szabo L (1990) Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features. J Bacteriol 172:1121
Cherry JD, Brunell PA, Golden GS, Karzon DT (1988) Report of the task force on pertussis and pertussis immunization-1988. Pediatrics 81:939
Cody CL, Baraff J, Cherry JD, Marcy SM, Manclark CR (1981) Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 68:650
Coote JG (1991) Antigenic switching and pathogenicity: environmental effects on virulence gene expression in Bordetella pertussis. J Gen Microbiol 137:2493
Corbel MJ, Abraham AM (1992) Agglutination of Bordetella species by lectins. FEMS Microbiol Letters 90:245
Dolby JM, Ackers JP (1975) Taxonomic distribution of the antigen eliciting bactericidal antibody for Bordetella pertussis. J Gen Microbiol 87:239
Dolby JM, Dolby DE (1969) The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis. Immunol 16:737
Edwards KM, Karzon DT (1990) Pertussis vaccines. Pediatr Clin North Am 37:549
Gotto J, Eckhardt T, Scott J, Woods D (1992) Protective effect of Bordetella pertussis lipopolysaccharide in the rat intratracheal challenge model of pertussis. Abstracts of the 92nd Annual Meeting of the American Society for Microbiology. ASM, New Orleans, p 146
Hamel J, Cazeault C, Brodeur BR (1992) Idiotypic analysis of a protective anti-B. pertussis LOS monoclonal antibody. Abstracts of the 92nd Annual Meeting of the American Society for Microbiology. ASM, New Orleans, p 121
Holst O, Brade H (1992) Chemical structure of the core region of lipopolysaccharides. In: Morrison DC, Ryan JL (eds) Bacterial endotoxic lipopolysaccharides, vol 1. CRC Press, Ann Arbor, pp 135–170
Kasuga T, Nakase Y, Ukishima K, Takatsu K (1954) Studies on Haemophilus pertussis. III. Some properties of each phase of H. pertussis. Kitasato Arch Exp Med 27:37
Lacey BW (1960) Antigenic modulation of Bordetella pertussis. J Hyg 58:57
LeDur A, Caroff M, Chaby R, Szabo L (1978) A novel type of endotoxin structure present in Bordetella pertussis. Isolation of two different polysaccharides bound to lipid A. Eur J Biochem 84:579
Leslie PH, Gardner AD (1931) The phases of Haemophilus pertussis. J Hyg Camb 31:423
Li ZM, Cowell JL, Brennan MJ, Burns DL, Manclark CR (1988) Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun 56:699
MacLennan AP (1960) Specific lipopolysaccharides of Bordetella. Biochem J 74:398
Manclark CR, Cowell JL (1984) Pertussis. In: Germanier R (ed) Bacterial vaccines. Academic Press, New York, pp 69–106
Martin D, Peppler MS, Brodeur BR (1992) Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis. Infect Immun 60:2718
McPheat WL, Wardlaw AC, Novotny P (1983) Modulation of Bordetella pertussis by nicotinic acid. Infect Immun 41:516
Miller DL, Ross EM, Alderslade R, Bellman MH, Rawson NSB (1981) Pertussis immunization and serious acute neurological illness in children. Br Med J 282:1595
Moreau M, Chaby R, Szabo L (1984) Structure of the terminal reducing heptasaccharide of polysaccaride 1 isolated from the Bordetella pertussis endotoxin. J Bacteriol 159:611
Mortimer EA (1988) Pertussis vaccine. In: Plotkin SA, Mortimer EA (eds) Vaccines. WB Saunders, Philadelphia, pp 74–96
Mortimer EA Jr (1990) Pertussis and pertussis vaccine. Adv Pediatr Infect 5:1
Mortimer EA, Jones PK (1979) An evaluation of pertussis vaccine. Rev Infect Dis 1:927
Mountzouros KT, Kimura A, Cowell JL (1992) A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosal infection with B. pertussis. Infect Immun 60:5316
Musser JM, Hewlett EL, Peppler MS, Selander RK (1986) Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol 166:230
Nakase Y, Tateisi M, Sekiya K, Kasuga T (1970) Chemical and biological properties of the purified O antigen of Bordetella pertussis. Jpn J Microbiol 14:1
Peppler MS (1984) Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants. Infect Immun 43:224
Pusztai Z, Csizér Z, Joo I (1971) The role and specificity of Bordetella lipopolysaccharide in immune reactions. Z Immunitätsforsch 141:129
Ray A, Redhead K, Selkirk S, Poole S (1991) Variability in LPS composition, antigenicity and reactogenicity of phase variants of Bordetella pertussis. FEMS Microbiol Lett 79:211
Romanus V, Jonsell R, Bergquist SO (1987) Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr Infect Dis J 6:364
Shahin RD, Brennan MJ, Li ZM, Meade BD, Manclark CR (1990) Characterization of the protective capacity and immunogenicity of the 69kd outer membrane protein of Bordetella pertussis. J Exp Med 171:63
Shahin RD, Hamel J, Brodeur BR, Leef MF (1992) Analysis of protective and non-protective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide. Abstracts of the 92nd Annual Meeting of the American Society for Microbiology. ASM, New Orelans, p 121
Szabo P, Szabo L (1991) Synthesis of 2-deoxy-4-O-α-and-β-d-mannopyranosyl-l-erythropentonic acids. Carbohydr Res 216:245
Walsh JA, Warren KS (1979) Selective primary health care: an interim strategy for disease control in developing countries. N Engl J Med 301:967
Wardlaw AC, Parton R (1983) Bordetella pertussis toxins. Pharmacol Ther 19:1
Watanabe M, Takimoto H, Kumazawa Y, Amano KI (1990) Biological properties of lipopolysaccharides from Bordetella species. J Gen Microbiol 136:489
Weiss AA, Hewlett EL (1986) Virulence factors of Bordetella pertussis. Annu Rev Microbiol 40:661
Weiss AA, Hewlett EL, Myers EG, Falkow S (1983) Tn-5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun 42:33
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brodeur, B.R., Martin, D., Hamel, J. et al. Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis . Springer Semin Immunopathol 15, 205–215 (1993). https://doi.org/10.1007/BF00201101
Issue Date:
DOI: https://doi.org/10.1007/BF00201101